ES546381A0 - Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina. - Google Patents
Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina.Info
- Publication number
- ES546381A0 ES546381A0 ES546381A ES546381A ES546381A0 ES 546381 A0 ES546381 A0 ES 546381A0 ES 546381 A ES546381 A ES 546381A ES 546381 A ES546381 A ES 546381A ES 546381 A0 ES546381 A0 ES 546381A0
- Authority
- ES
- Spain
- Prior art keywords
- butirolactamas
- medicine
- procedures
- obtaining
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Joining Of Building Structures In Genera (AREA)
- Package Frames And Binding Bands (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843431257 DE3431257A1 (de) | 1984-08-24 | 1984-08-24 | Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES546381A0 true ES546381A0 (es) | 1986-07-16 |
| ES8609241A1 ES8609241A1 (es) | 1986-07-16 |
Family
ID=6243847
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES546381A Expired ES8609241A1 (es) | 1984-08-24 | 1985-08-23 | Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina. |
| ES554061A Expired ES8704457A1 (es) | 1984-08-24 | 1986-04-16 | Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES554061A Expired ES8704457A1 (es) | 1984-08-24 | 1986-04-16 | Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4879390A (es) |
| EP (1) | EP0172514B1 (es) |
| JP (1) | JPH0660159B2 (es) |
| KR (1) | KR860001787A (es) |
| AT (1) | ATE46504T1 (es) |
| AU (1) | AU571729B2 (es) |
| CA (1) | CA1262250A (es) |
| DE (2) | DE3431257A1 (es) |
| DK (1) | DK385285A (es) |
| ES (2) | ES8609241A1 (es) |
| FI (1) | FI853228L (es) |
| GR (1) | GR852050B (es) |
| HU (1) | HU195774B (es) |
| IL (1) | IL76157A (es) |
| PT (1) | PT81005B (es) |
| ZA (1) | ZA856414B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU579029B2 (en) * | 1985-10-18 | 1988-11-10 | Bayer Aktiengesellschaft | Process for the preparation of ` -butyrolactams |
| DE3616989A1 (de) * | 1986-05-21 | 1987-11-26 | Bayer Ag | Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung |
| DE3927370A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate |
| DE3927367A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere |
| JP4585073B2 (ja) * | 2000-02-15 | 2010-11-24 | 丸善製薬株式会社 | 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品 |
| US6787564B2 (en) * | 2002-03-26 | 2004-09-07 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use |
| EP1348696B1 (en) * | 2002-03-26 | 2012-02-01 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same |
| CN1295215C (zh) * | 2002-12-31 | 2007-01-17 | 中国医学科学院药物研究所 | 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途 |
| WO2016015333A1 (en) * | 2014-08-01 | 2016-02-04 | F.Hoffmann-La Roche Ag | 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI325174A (es) * | 1973-11-19 | 1975-05-20 | Sandoz Ag |
-
1984
- 1984-08-24 DE DE19843431257 patent/DE3431257A1/de not_active Withdrawn
-
1985
- 1985-08-12 DE DE8585110087T patent/DE3573113D1/de not_active Expired
- 1985-08-12 AT AT85110087T patent/ATE46504T1/de not_active IP Right Cessation
- 1985-08-12 EP EP85110087A patent/EP0172514B1/en not_active Expired
- 1985-08-21 IL IL76157A patent/IL76157A/xx unknown
- 1985-08-22 FI FI853228A patent/FI853228L/fi not_active Application Discontinuation
- 1985-08-22 JP JP60183161A patent/JPH0660159B2/ja not_active Expired - Lifetime
- 1985-08-22 AU AU46571/85A patent/AU571729B2/en not_active Ceased
- 1985-08-22 PT PT81005A patent/PT81005B/pt unknown
- 1985-08-22 CA CA000489253A patent/CA1262250A/en not_active Expired
- 1985-08-23 ES ES546381A patent/ES8609241A1/es not_active Expired
- 1985-08-23 HU HU853219A patent/HU195774B/hu not_active IP Right Cessation
- 1985-08-23 GR GR852050A patent/GR852050B/el unknown
- 1985-08-23 DK DK385285A patent/DK385285A/da not_active Application Discontinuation
- 1985-08-23 ZA ZA856414A patent/ZA856414B/xx unknown
- 1985-08-23 KR KR1019850006078A patent/KR860001787A/ko not_active IP Right Cessation
-
1986
- 1986-04-16 ES ES554061A patent/ES8704457A1/es not_active Expired
-
1988
- 1988-04-27 US US07/186,540 patent/US4879390A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK385285A (da) | 1986-02-25 |
| KR860001787A (ko) | 1986-03-22 |
| JPH0660159B2 (ja) | 1994-08-10 |
| EP0172514A1 (en) | 1986-02-26 |
| PT81005A (en) | 1985-09-01 |
| US4879390A (en) | 1989-11-07 |
| PT81005B (en) | 1987-06-26 |
| ES8704457A1 (es) | 1987-04-01 |
| EP0172514B1 (en) | 1989-09-20 |
| HUT38904A (en) | 1986-07-28 |
| AU571729B2 (en) | 1988-04-21 |
| GR852050B (es) | 1985-12-20 |
| ES8609241A1 (es) | 1986-07-16 |
| IL76157A (en) | 1988-08-31 |
| ES554061A0 (es) | 1987-04-01 |
| HU195774B (en) | 1988-07-28 |
| DK385285D0 (da) | 1985-08-23 |
| FI853228A0 (fi) | 1985-08-22 |
| ATE46504T1 (de) | 1989-10-15 |
| ZA856414B (en) | 1986-04-30 |
| DE3431257A1 (de) | 1986-03-06 |
| FI853228L (fi) | 1986-02-25 |
| CA1262250A (en) | 1989-10-10 |
| AU4657185A (en) | 1986-02-27 |
| DE3573113D1 (en) | 1989-10-26 |
| IL76157A0 (en) | 1985-12-31 |
| JPS62181250A (ja) | 1987-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8801785A1 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
| IL89835A0 (en) | Substituted azetidinones,their preparation and pharmaceutical compositions containing them | |
| DE2861170D1 (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture | |
| ES2196082T3 (es) | Analagos del factor de crecimiento de queratinocitos. | |
| IT1098253B (it) | Propenil-ammine,procedimenti per la loro produzione,e composizioni farmaceutiche che le contengono | |
| IL55801A0 (en) | Novel proline derivatives and homologues thereof,their production and pharmaceutical compositions containing them | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| ES546381A0 (es) | Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina. | |
| BE883096A (fr) | Procede de preparation de concentres de complexe prothrombinique hautement purifies, concentres obtenus et leur application | |
| IT1180748B (it) | Eteri amminociclopentilici,procedimento per prepararli e composizione farmaceutica che li comprende | |
| IT1182061B (it) | Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene | |
| LU80476A1 (fr) | Nouvelles 4-quinolyl-guanidines,utiles notamment comme anti-inflammatoires,et leur procede de preparation | |
| FR2567519B1 (fr) | Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation | |
| IT1141135B (it) | Derivati peptidici,procedimento per prepararli e relative composizioni farmaceutiche | |
| ES2128313T3 (es) | Naftalimidas n-substituidas, su obtencion y empleo. | |
| BE883576A (fr) | Nouveaux derives d'hydroxyamino-eburnane leur procede de preparation, intermediaires utiles et utilisation comme medicament et comme intermediaire | |
| IT1177147B (it) | Composizione farmaceutica per combattere infezioni virali, e procedimento di uso per le infezioni virali | |
| BE869833A (fr) | 2,3-polymethylene-4-oxo-4h-pyrido(1,2-a) pyrimidines utiles comme medicaments et procede pour leur preparation | |
| IT1098051B (it) | Derivati antiflogistici di 1-feniletanolammina,loro composizione farmaceutiche,e procedimenti per la loro fabbricazione | |
| IT7828215A0 (it) | Procedimenti per la produzione dicomposti organici,in particolare tienobenzazepine e composizioni farmaceutiche relative | |
| BE877982A (fr) | Nouvelles 2-(5-pyrazolylamido)-2-imidazolines, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant | |
| FR2398070A1 (fr) | Nouvelles 1-piperazinyl-triazolo-thieno-1,4-diazepines substituees et leur application comme medicaments | |
| MY103900A (en) | 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions | |
| IT8421194A1 (it) | Derivati del propafenone, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| IT8321358A1 (it) | Derivati ad attività terapeutica della S-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |